<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJAnes</journal-id><journal-title-group><journal-title>Open Journal of Anesthesiology</journal-title></journal-title-group><issn pub-type="epub">2164-5531</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojanes.2020.105018</article-id><article-id pub-id-type="publisher-id">OJAnes-100528</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Dexmedetomidine versus Ketamine for the Prevention of Emergence Agitation in Pediatric: A Prospective, Randomized, and Controlled Clinical Trial
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Elsayed</surname><given-names>Mohamed Abdelzaam</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Enas</surname><given-names>W. Mahdy</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Anesthesiology, Faculty of Medicine, Benha University, Benha, Egypt</addr-line></aff><pub-date pub-type="epub"><day>09</day><month>05</month><year>2020</year></pub-date><volume>10</volume><issue>05</issue><fpage>203</fpage><lpage>212</lpage><history><date date-type="received"><day>20,</day>	<month>April</month>	<year>2020</year></date><date date-type="rev-recd"><day>25,</day>	<month>May</month>	<year>2020</year>	</date><date date-type="accepted"><day>28,</day>	<month>May</month>	<year>2020</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: This study compares the effect of dexmedetomidine versus Ketamine for the prevention of emergence agitation in children undergoing general anaesthesia. 
  Method: 75 Children are randomly allocated into three groups. Group C: Were assigned to receive normal saline. Group K: Were assigned to receive Ketamine 0.25 mg/kg. Group D: assigned to receive 0.25 ug /kg of dexmedetomidine, before the end of surgery. 
  Results: There was no statistically significant difference in demographic data and intraoperative parameters between the three groups. But as regards to time to discharge, there was a significant difference between group C, group K and group D (group C = 39.96 &#177; 2.84, group K = 37.28 &#177; 3.80, group D = 35.08 &#177; 3.36 and P value = 0.0002). FLACC scale was low after extubation, before leaving the operating room and on arrival to PACU (small FLACC scale in group K, D than group C). PAED scoreless in Group K and Group D than Group C (postoperative, at 10 minutes, 20 min, 30 min). 
  Conclusion: Ketamine and dexmedetomidine reduced the incidence and severity of emergence delirium effectively when compared to normal saline, and the effects of dexmedetomidine being much superior to Ketamine.
 
</p></abstract><kwd-group><kwd>Emergence Agitation</kwd><kwd> Ketamine</kwd><kwd> Dexmedetomidine</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Emergence agitation in children is a common problem in pediatric patients which includes manifestations such as crying, excitation, agitation, delirium, and behavioural disturbances during early emergence from general anaesthesia and continues through the initial recovery period [<xref ref-type="bibr" rid="scirp.100528-ref1">1</xref>].</p><p>The true incidence of emergence agitation is unclear. Still, it can occur in as many as 30 to 50 percents of children who have general anaesthesia, and it is essential to diagnose emergence agitation, pain must control entirely [<xref ref-type="bibr" rid="scirp.100528-ref2">2</xref>].</p><p>Sevoflurane commonly used as an inhalational anaesthetic for pediatric patients. Sevoflurane induction can be achieved quickly and safely by inhalation using a mask, sevoflurane does not cause substantial hemodynamic changes, and return to the preoperative level of consciousness following anesthesia is rapid. However, sevoflurane can result in emergence agitation. The incidence of emergence agitation after sevoflurane anaesthesia estimated at 80%. Emergence agitation occurs most frequently in preschool children during the early stage of emergence from anaesthesia [<xref ref-type="bibr" rid="scirp.100528-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.100528-ref4">4</xref>].</p><p>This emergence of agitation must manage by providing smooth emergence to pediatric patients. Under other circumstances, uncooperative, an irritable, inconsolable, and crying child with excessive motor activity may cause many complications for the parents, nursing and maybe children also harm themselves [<xref ref-type="bibr" rid="scirp.100528-ref5">5</xref>].</p><p>Although EA is commonly self-limited and happens within the first 30 min of stay in a postanesthesia care unit (PACU) and also can lead to disconnection of monitoring devices or intravenous catheters, physical damage, falling, increase in the risk of bleeding, and self-extubation [<xref ref-type="bibr" rid="scirp.100528-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.100528-ref7">7</xref>].</p><p>There are many factors to decrease the incidence of emergence agitation, such as Parental presence at emergence, physical restraints, or pharmacologic interventions [<xref ref-type="bibr" rid="scirp.100528-ref8">8</xref>]. But pharmacologic interventions remain to be the better method. Different studies proved that medications such as ketamine propofol, fentanyl, ketofol, dexmedetomidine, clonidine, and midazolam had used to reduce the incidence of emergence agitation [<xref ref-type="bibr" rid="scirp.100528-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.100528-ref10">10</xref>].</p><p>This study compares the effect of dexmedetomidine versus Ketamine for the prevention of emergence agitation in children undergoing general anaesthesia.</p></sec><sec id="s2"><title>2. Patients and Method</title><p>After approval of the institutional ethics committee and written informed consent by the parents of children, children aged ranged between 6 and 10 years belonging to ASA grade I and II scheduled for elective tonsillectomy, adenoidectomy or both. These patients randomly allocated for this prospective, randomized, controlled, study which conducted in Benha university hospitals from August 2019 to March 2020.</p><p>Exclusion criteria included children with developmental problems, inborn errors of metabolism, cerebral palsy, down syndrome, a history of epileptic fits, body weight less than 10 kg or greater than 30 kg (children below the age of 6 years with body weight more than 30 kg are obese with a risk of airway obstruction); patients with previous history of agitation after sevoflurane anesthesia and patients with respiratory distress of any cause; also, children with known allergy to any of the medications used. Patients are randomly assigned via computer-generated random to three groups.</p><p>&#183; Group C: Were assigned to receive normal saline (as a placebo) in a single syringe, the total volume made up to 10 ml. was given 10 min before the end of surgery.</p><p>&#183; Group K: Were assigned to receive Ketamine 0.25 mg/kg in a single syringe, the total volume made up to 10 ml. was given 10 min before the end of surgery.</p><p>&#183; Group D: Were assigned to receive 0.25 ug /kg of dexmedetomidine, the total volume made up to 10 ml to ensure blinding, was given 10 min before the end of surgery.</p><p>All the children must fast 6 h for solid &amp; 3 h for clear fluid. All the children were premedicated with oral midazolam 0.25 mg/kg 25 min before surgery. General anaesthesia induction was done by the gradual rise of sevoflurane concentration to reach a maximum of 6 Vol. % in 100% oxygen (6 L/min) through a facemask. After the loss of eyelash reflex, started to insert of an intravenous (IV) catheter and the airway was secured with an oral end tracheal tube after an adequate depth of anaesthesia reached with fentanyl 1 μg/kg and cisatracurium 0.1 mg/kg. Oxygen saturation (SpO<sub>2</sub>), electrocardiogram, heart rate (HR), mean arterial pressure, end‑tidal CO<sub>2</sub> concentration (EtCO<sub>2</sub>), and end‑tidal sevoflurane concentration were monitored continuously. Sevoflurane concentration maintained at 2 - 4 Vol, All the patients, were ventilated to keep an end-tidal CO<sub>2</sub> of 30 - 35 mmHg. Data collection and monitoring were done by another a junior resident who was unknowing of the study drugs and allocation. Then at the end of the surgery, sevoflurane was discontinued, the reversal of neuromuscular block done by neostigmine bromide 20 μg/kg plus atropine sulfate 20 μg/kg, and when the patients met the criteria of extubation, the end tracheal tube was removed in lateral decubitus. The interval time from the end of surgery to tracheal extubation defined as the time of extubation and the time of first response to command or eye-opening on command after extubation defined as emergence time that also recorded. The duration of surgery defined as the time between the insertion and removal of the mouth gag and also recorded it and the time from sevoflurane mask induction until the extubation time recorded as the duration of anaesthesia. After extubation, children were shifted to the post-anaesthetic care unit (PACU) and monitored for the following parameters until they moved to the ward.</p><p>&#183; Hemodynamic parameters: Heart rate (HR), Noninvasive blood pressure (NIBP), and Oxygen saturation (SpO<sub>2</sub>), at the same six-time points (after extubation, then on leaving the OR, on arrival to PACU, at 10, 20, and also at 30 min after arrival in PACU).</p><p>Pain assessment was done by using Face, Legs, Activity, Cry, and Consolability (FLACC) scale at the same six-time points (after extubation, then on leaving the OR, and also on arrival to PACU, at 10, 20, and even at 30 min after arrival in PACU). Nalbuphine as a rescue analgesic at a dose of 0.1 mg/kg is given if FLACC scores ≥ 5 (<xref ref-type="table" rid="table1">Table 1</xref>) [<xref ref-type="bibr" rid="scirp.100528-ref11">11</xref>].</p><p>The severity of emergence delirium evaluated using the pediatric anaesthesia emergence delirium scale (PAED) (<xref ref-type="table" rid="table2">Table 2</xref>) with scores ranging from 0 to 20. PAED scale was monitored immediately after emergence and at 10 min intervals after that until discharge from PACU (<xref ref-type="table" rid="table2">Table 2</xref>) [<xref ref-type="bibr" rid="scirp.100528-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.100528-ref13">13</xref>].</p><p>Patients transferred to the ward after being fully conscious with stable vital signs, calm, PAED score &lt; 10. FLACC score &lt; 5 and the absence of bleeding, pain, nausea or vomiting.</p>Statistical Analysis<p>Analysis of data is done by using SPSS Version 16. Quantitative data were presented as mean &#177; Standard deviation and analyzed by using the one way ANOVA test. Qualitative data were presented as numbers and percentages and analyzed by using the Chi-square test and Fisher exact test. We used repeated measure ANOVA test yo analyzed the Quantitative data of repeated measures in the same group, and the significant rules detected by post-hoc analysis. P-Value &lt; 0.05 was considered statistically significant, and P-Value &lt; 0.01 was considered statistically highly significant.</p><p>The sample size was determined to assume that the likelihood of sevoflurane</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> FLACC score</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="3"  >Score</th><th align="center" valign="middle"  rowspan="2"  >Category</th></tr></thead><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Frequent to constant frown</td><td align="center" valign="middle" >Occasional grimace</td><td align="center" valign="middle" >No particular expression or smile</td><td align="center" valign="middle" >Face</td></tr><tr><td align="center" valign="middle" >Kicking or leg drawn up</td><td align="center" valign="middle" >Uneasy, restless</td><td align="center" valign="middle" >Normal Position</td><td align="center" valign="middle" >Legs</td></tr><tr><td align="center" valign="middle" >Arched rigid</td><td align="center" valign="middle" >Squirming, shifting Back</td><td align="center" valign="middle" >Lying quietly moves quickly.</td><td align="center" valign="middle" >Activity</td></tr><tr><td align="center" valign="middle" >Crying steadily Screams</td><td align="center" valign="middle" >Moans or whimpers</td><td align="center" valign="middle" >No crying</td><td align="center" valign="middle" >Cry</td></tr><tr><td align="center" valign="middle" >Difficult to console</td><td align="center" valign="middle" >Reassured by occasional touching, hugging</td><td align="center" valign="middle" >Content, relaxed</td><td align="center" valign="middle" >Consolability</td></tr></tbody></table></table-wrap><p>Each scale was added and expressed as total points. [<xref ref-type="bibr" rid="scirp.100528-ref11">11</xref>]</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> PAED score Pediatric Anesthesia Emergence Delirium (PAED) scales</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Point</th><th align="center" valign="middle" >Description of items</th><th align="center" valign="middle" >Not at all</th><th align="center" valign="middle" >Just a little</th><th align="center" valign="middle" >Quite a bit</th><th align="center" valign="middle" >Very much</th><th align="center" valign="middle" >extremely</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >The child makes eye contact with the caregiver</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >The child’s actions are purposeful</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >The child is aware of his/her surroundings</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >The child is restless</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >4</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >The child is inconsolable</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >4</td></tr></tbody></table></table-wrap><p>One-calm, two-not calm but could be easily consoled, three-moderately agitated or restless and not quickly quiet, four-combative, excited and thrashing around. PAED: Pediatric emergency delirium scale [<xref ref-type="bibr" rid="scirp.100528-ref12">12</xref>].</p><p>agitation was 30% or more. We needed to find a significant difference (P &lt; 0.05) (α = 0.05, one-tailed) with a power of 90% (error = 0.1) to detect a difference of 25%. Twenty-one patients per group would have been sufficient. Still, we expected some exclusions from the protocol (which did not happen) and increased this number to 25 (which allowed finding the same significant difference with a power of 90%).</p></sec><sec id="s3"><title>3. Result</title><p>The total number of patients registered during the study period was 75 in three groups 25 in each group. All the patients who enrolled in the study completed the study. The three groups were comparable for demographic characters as represented in <xref ref-type="table" rid="table3">Table 3</xref>, and as regards to the duration of surgery, duration of anaesthesia, emergence of time and time of discharge in <xref ref-type="table" rid="table4">Table 4</xref>. Heart rate between the three groups is shown in <xref ref-type="table" rid="table5">Table 5</xref> and mean arterial pressure (<xref ref-type="table" rid="table6">Table 6</xref>). Oxygen saturation between the three groups is presented in <xref ref-type="table" rid="table7">Table 7</xref> and FLACC scale is presented in <xref ref-type="table" rid="table8">Table 8</xref>. PAED score was showed in <xref ref-type="table" rid="table9">Table 9</xref>.</p><p>There were no significant differences between the three groups as regard age, weight, sex (male or female), ASA grade (I or II) and type of surgery (<xref ref-type="table" rid="table3">Table 3</xref>).</p><p>There were no significant differences between the three groups as regards to</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Demographic data in groups (mean &#177; SD)</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"  ></th><th align="center" valign="middle" >Group C N = 25</th><th align="center" valign="middle" >Group K N = 25</th><th align="center" valign="middle" >Group D N = 25</th><th align="center" valign="middle" >p-value</th></tr></thead><tr><td align="center" valign="middle"  colspan="2"  >Age (yrs.)</td><td align="center" valign="middle" >5.64 &#177; 1.46</td><td align="center" valign="middle" >5.58 &#177; 1.91</td><td align="center" valign="middle" >6 &#177; 2.10</td><td align="center" valign="middle" >0.37</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Weight (kg)</td><td align="center" valign="middle" >19.94 &#177; 4.24</td><td align="center" valign="middle" >19.85 &#177; 5.36</td><td align="center" valign="middle" >19.89 &#177; 6.04</td><td align="center" valign="middle" >0.99</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Sex</td><td align="center" valign="middle" >M</td><td align="center" valign="middle" >17 (68%)</td><td align="center" valign="middle" >15 (60%)</td><td align="center" valign="middle" >18 (72%)</td><td align="center" valign="middle"  rowspan="2"  >0.65</td></tr><tr><td align="center" valign="middle" >F</td><td align="center" valign="middle" >8 (32%)</td><td align="center" valign="middle" >10 (40%)</td><td align="center" valign="middle" >7 (28%)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >ASA</td><td align="center" valign="middle" >I</td><td align="center" valign="middle" >20 (80%)</td><td align="center" valign="middle" >18 (72%)</td><td align="center" valign="middle" >19 (76%)</td><td align="center" valign="middle"  rowspan="2"  >0.80</td></tr><tr><td align="center" valign="middle" >II</td><td align="center" valign="middle" >5 (20%)</td><td align="center" valign="middle" >7 (28%)</td><td align="center" valign="middle" >6 (24%)</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Type of surgery</td><td align="center" valign="middle" >Tonsillectomy</td><td align="center" valign="middle" >10 (40%)</td><td align="center" valign="middle" >11 (44%)</td><td align="center" valign="middle" >9 (36%)</td><td align="center" valign="middle"  rowspan="3"  >0.98</td></tr><tr><td align="center" valign="middle" >Adenoid</td><td align="center" valign="middle" >5 (20%)</td><td align="center" valign="middle" >5 (20%)</td><td align="center" valign="middle" >6 (24%)</td></tr><tr><td align="center" valign="middle" >adenotonsillectomy</td><td align="center" valign="middle" >10 (40%)</td><td align="center" valign="middle" >9 (36%)</td><td align="center" valign="middle" >10 (40%)</td></tr></tbody></table></table-wrap><p>Data presented as mean &#177; SD. Gender presented as numbers.</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Intraoperative parameters (mean &#177; SD</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Group C N = 25</th><th align="center" valign="middle" >Group K N = 25</th><th align="center" valign="middle" >Group D N = 25</th><th align="center" valign="middle" >p-value</th></tr></thead><tr><td align="center" valign="middle" >Duration of anaesthesia</td><td align="center" valign="middle" >28.12 &#177; 4.26</td><td align="center" valign="middle" >28.64 &#177; 3.59</td><td align="center" valign="middle" >28.84 &#177; 3.32</td><td align="center" valign="middle" >0.78</td></tr><tr><td align="center" valign="middle" >Duration of surgery</td><td align="center" valign="middle" >19.64 &#177; 3.03</td><td align="center" valign="middle" >19.12 &#177; 3.35</td><td align="center" valign="middle" >19.16 &#177; 2.96</td><td align="center" valign="middle" >0.80</td></tr><tr><td align="center" valign="middle" >Emergence of time</td><td align="center" valign="middle" >12.8 &#177; 1.65</td><td align="center" valign="middle" >12.4 &#177; 1.25</td><td align="center" valign="middle" >12.04 &#177; 0.88</td><td align="center" valign="middle" >0.12</td></tr><tr><td align="center" valign="middle" >Time to discharge</td><td align="center" valign="middle" >39.96 &#177; 2.84</td><td align="center" valign="middle" >37.28 &#177; 3.80</td><td align="center" valign="middle" >35.08 &#177; 3.36</td><td align="center" valign="middle" >0.0002*</td></tr></tbody></table></table-wrap><p>Values are expressed when Mean &#177; SD or Number (%). *P &lt; 0.05, statistically significant. C: control, K: ketamine, D: Dexmedetomidine.</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Show heart rate between the three groups (mean &#177; SD)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >HR (beat/min.)</th><th align="center" valign="middle" >Group C N = 25</th><th align="center" valign="middle" >Group K N = 25</th><th align="center" valign="middle" >GROUP D N = 25</th><th align="center" valign="middle" >p-value</th></tr></thead><tr><td align="center" valign="middle" >After extubation</td><td align="center" valign="middle" >113.24 &#177; 4.85</td><td align="center" valign="middle" >117.36 &#177; 6.54</td><td align="center" valign="middle" >113.16 &#177; 9.09</td><td align="center" valign="middle" >0.06</td></tr><tr><td align="center" valign="middle" >Before leaving OR</td><td align="center" valign="middle" >98.28 &#177; 4.86</td><td align="center" valign="middle" >103.52 &#177; 4.43</td><td align="center" valign="middle" >98.92 &#177; 5.52</td><td align="center" valign="middle" >0.005*</td></tr><tr><td align="center" valign="middle" >On arrival to PACU</td><td align="center" valign="middle" >96.88 &#177; 5.67</td><td align="center" valign="middle" >100.4 &#177; 6.57</td><td align="center" valign="middle" >95.96 &#177; 6.47</td><td align="center" valign="middle" >0.03*</td></tr><tr><td align="center" valign="middle" >10 min. postoperative</td><td align="center" valign="middle" >93.8 &#177; 3.89</td><td align="center" valign="middle" >93.24 &#177; 4.21</td><td align="center" valign="middle" >93.84 &#177; 4.59</td><td align="center" valign="middle" >0.8</td></tr><tr><td align="center" valign="middle" >20 min. postoperative</td><td align="center" valign="middle" >93.16 &#177; 3.7</td><td align="center" valign="middle" >93.48 &#177; 4.80</td><td align="center" valign="middle" >93.04 &#177; 4.07</td><td align="center" valign="middle" >0.9</td></tr><tr><td align="center" valign="middle" >30 min. postoperative</td><td align="center" valign="middle" >92.12 &#177; 3.05</td><td align="center" valign="middle" >92.56 &#177; 3.67</td><td align="center" valign="middle" >92.64 &#177; 4.57</td><td align="center" valign="middle" >0.8</td></tr></tbody></table></table-wrap><p>Values are expressed when Mean &#177; SD or Number (%) *P &lt; 0.05, statistically significant. C: control, K: ketamine, D: Dexmedetomidine. Bpm: Beats per minute.</p><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> Show Mean Arterial Pressure between the three groups. (mean &#177; SD)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >MAP (mmHg)</th><th align="center" valign="middle" >Group C</th><th align="center" valign="middle" >Group K</th><th align="center" valign="middle" >GROUP D</th><th align="center" valign="middle" >p-value</th></tr></thead><tr><td align="center" valign="middle" >After extubation</td><td align="center" valign="middle" >55.2 &#177; 4.44</td><td align="center" valign="middle" >55.04 &#177; 5.99</td><td align="center" valign="middle" >52.88 &#177; 11.88</td><td align="center" valign="middle" >0.52</td></tr><tr><td align="center" valign="middle" >Before leaving OR</td><td align="center" valign="middle" >54.84 &#177; 4.25</td><td align="center" valign="middle" >54.64 &#177; 3.8</td><td align="center" valign="middle" >54.4 &#177; 4.07</td><td align="center" valign="middle" >0.93</td></tr><tr><td align="center" valign="middle" >On arrival to PACU</td><td align="center" valign="middle" >53.08 &#177; 4.29</td><td align="center" valign="middle" >53.04 &#177; 5.37</td><td align="center" valign="middle" >52.68 &#177; 4.72</td><td align="center" valign="middle" >0.95</td></tr><tr><td align="center" valign="middle" >10 min.</td><td align="center" valign="middle" >52.44 &#177; 3.79</td><td align="center" valign="middle" >52.2 &#177; 4.24</td><td align="center" valign="middle" >54.12 &#177; 3.29</td><td align="center" valign="middle" >0.95</td></tr><tr><td align="center" valign="middle" >20 min.</td><td align="center" valign="middle" >50.48 &#177; 3.38</td><td align="center" valign="middle" >49.36 &#177; 4.05</td><td align="center" valign="middle" >49.48 &#177; 4.36</td><td align="center" valign="middle" >0.54</td></tr><tr><td align="center" valign="middle" >30 min.</td><td align="center" valign="middle" >46.76 &#177; 3.39</td><td align="center" valign="middle" >46.12 &#177; 3.96</td><td align="center" valign="middle" >46.08 &#177; 3.88</td><td align="center" valign="middle" >0.77</td></tr></tbody></table></table-wrap><p>Values are expressed when Mean &#177; SD or Number (%). *P &lt; 0.05, statistically significant. C: control, K: ketamine, D: Dexmedetomidine.</p><table-wrap id="table7" ><label><xref ref-type="table" rid="table7">Table 7</xref></label><caption><title> Show oxygen saturation between the three groups. (mean &#177; SD</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >SPO<sub>2</sub> (%)</th><th align="center" valign="middle" >Group C</th><th align="center" valign="middle" >Group K</th><th align="center" valign="middle" >GROUP D</th><th align="center" valign="middle" >p-value</th></tr></thead><tr><td align="center" valign="middle" >After extubation</td><td align="center" valign="middle" >99.6 &#177; 0.57</td><td align="center" valign="middle" >99.68 &#177; 0.55</td><td align="center" valign="middle" >99.48 &#177; 0.87</td><td align="center" valign="middle" >0.58</td></tr><tr><td align="center" valign="middle" >Before leaving OR</td><td align="center" valign="middle" >99.72 &#177; 0.59</td><td align="center" valign="middle" >99.72 &#177; 0.67</td><td align="center" valign="middle" >99.44 &#177; 0.82</td><td align="center" valign="middle" >0.25</td></tr><tr><td align="center" valign="middle" >On arrival to PACU</td><td align="center" valign="middle" >99.64 &#177; 0.56</td><td align="center" valign="middle" >99.4 &#177; 0.86</td><td align="center" valign="middle" >99.16 &#177; 1.02</td><td align="center" valign="middle" >0.13</td></tr><tr><td align="center" valign="middle" >10 min.</td><td align="center" valign="middle" >99.64 &#177; 0.63</td><td align="center" valign="middle" >99.48 &#177; 0.96</td><td align="center" valign="middle" >99.72 &#177; 0,67</td><td align="center" valign="middle" >0.53</td></tr><tr><td align="center" valign="middle" >20 min.</td><td align="center" valign="middle" >99.6 &#177; 0.76</td><td align="center" valign="middle" >99.72 &#177; 0.73</td><td align="center" valign="middle" >99.4 &#177; 0.76</td><td align="center" valign="middle" >0.31</td></tr><tr><td align="center" valign="middle" >30 min.</td><td align="center" valign="middle" >99.52 &#177; 0.82</td><td align="center" valign="middle" >99.8 &#177; 0.5</td><td align="center" valign="middle" >99.28 &#177; 0.97</td><td align="center" valign="middle" >0.07</td></tr></tbody></table></table-wrap><p>Values are expressed when Mean &#177; SD or Number (%) *P &lt; 0.05, statistically significant. C: control, K: ketamine, D: Dexmedetomidine.</p><table-wrap id="table8" ><label><xref ref-type="table" rid="table8">Table 8</xref></label><caption><title> FLACC scale between three groups. (mean &#177; SD</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >FLACC scale</th><th align="center" valign="middle" >Group C</th><th align="center" valign="middle" >Group K</th><th align="center" valign="middle" >GROUP D</th><th align="center" valign="middle" >p-value</th></tr></thead><tr><td align="center" valign="middle" >After extubation</td><td align="center" valign="middle" >7.04 &#177; 1.76</td><td align="center" valign="middle" >5.76 &#177; 1.76</td><td align="center" valign="middle" >5.76 &#177; 1.45</td><td align="center" valign="middle" >0.009*</td></tr><tr><td align="center" valign="middle" >Before leaving OR</td><td align="center" valign="middle" >6.44 &#177; 1.44</td><td align="center" valign="middle" >4.84 &#177; 1.37</td><td align="center" valign="middle" >4.6 &#177; 1.15</td><td align="center" valign="middle" >0.006*</td></tr><tr><td align="center" valign="middle" >On arrival to PACU</td><td align="center" valign="middle" >6.04 &#177; 1.17</td><td align="center" valign="middle" >4.04 &#177; 0.84</td><td align="center" valign="middle" >3.96 &#177; 1.17</td><td align="center" valign="middle" >0.003*</td></tr><tr><td align="center" valign="middle" >10 min.</td><td align="center" valign="middle" >3.68 &#177; 0.85</td><td align="center" valign="middle" >3.2 &#177; 1.58</td><td align="center" valign="middle" >3.24 &#177; 0.87</td><td align="center" valign="middle" >0.26</td></tr><tr><td align="center" valign="middle" >20 min.</td><td align="center" valign="middle" >2.64 &#177; 1.03</td><td align="center" valign="middle" >2.44 &#177; 1.35</td><td align="center" valign="middle" >2.52 &#177; 0.82</td><td align="center" valign="middle" >0.81</td></tr><tr><td align="center" valign="middle" >30 min.</td><td align="center" valign="middle" >1.8 &#177; 1.32</td><td align="center" valign="middle" >1.8 &#177; 0.95</td><td align="center" valign="middle" >1.88 &#177; 1.01</td><td align="center" valign="middle" >0.95</td></tr></tbody></table></table-wrap><p>Values are expressed when Mean &#177; SD or Number (%) *P &lt; 0.05, statistically significant. C: control, K: ketamine, D: Dexmedetomidine.</p><table-wrap id="table9" ><label><xref ref-type="table" rid="table9">Table 9</xref></label><caption><title> PAED score between three groups. (mean &#177; SD)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >PAED score</th><th align="center" valign="middle" >Group C</th><th align="center" valign="middle" >Group K</th><th align="center" valign="middle" >GROUP D</th><th align="center" valign="middle" >p-value</th></tr></thead><tr><td align="center" valign="middle" >On arrival to PACU</td><td align="center" valign="middle" >13.4 &#177; 1.82</td><td align="center" valign="middle" >13.68 &#177; 1.86</td><td align="center" valign="middle" >13.16 &#177; 2.11</td><td align="center" valign="middle" >0.63</td></tr><tr><td align="center" valign="middle" >10 min.</td><td align="center" valign="middle" >11.96 &#177; 1.67</td><td align="center" valign="middle" >10.08 &#177; 1.46</td><td align="center" valign="middle" >9.32 &#177; 1.10</td><td align="center" valign="middle" >o.003*</td></tr><tr><td align="center" valign="middle" >20 min.</td><td align="center" valign="middle" >8.32 &#177; 1.14</td><td align="center" valign="middle" >5.48 &#177; .0.09</td><td align="center" valign="middle" >5.08 &#177; 1.03</td><td align="center" valign="middle" >0.001*</td></tr><tr><td align="center" valign="middle" >30 min.</td><td align="center" valign="middle" >4.64 &#177; 1.07</td><td align="center" valign="middle" >2.04 &#177; 0.97</td><td align="center" valign="middle" >1.2 &#177; 0.918</td><td align="center" valign="middle" >0.001*</td></tr></tbody></table></table-wrap><p>Values are expressed when Mean &#177; SD or Number (%) *P &lt; 0.05, statistically significant. C: control, K: ketamine, D: Dexmedetomidine.</p><p>the duration of surgery, duration of anaesthesia and emergence of time (<xref ref-type="table" rid="table4">Table 4</xref>). But as regards to time to discharge significant between-group C and group K and group D. Time of discharge in group K and group D were significantly less than group C, and time of discharge was lower in group D than group K (<xref ref-type="table" rid="table4">Table 4</xref>).</p><p>Also there were no significant differences between the three groups as regards to Heart rate after extubation, postoperative at 10, 20, 30 minutes but before leaving OR (OPERATING ROOM) and on arrival to PACU, there is rise of heart rate in the group K (<xref ref-type="table" rid="table5">Table 5</xref>).</p><p>There were no significant differences between the three groups as regards to mean arterial pressure between the three groups (<xref ref-type="table" rid="table6">Table 6</xref>). Also there were no significant differences between the three groups as regard to oxygen saturation between the three groups (<xref ref-type="table" rid="table7">Table 7</xref>).</p><p>There were significant differences between the three groups as regards to FLACC scale after extubation, before leaving the operating room (OR) and on arrival to PACU (low FLACC scale in group K, D than group C). But postoperative at 10, 20, 30 minutes, there were no significant differences between the three groups (<xref ref-type="table" rid="table8">Table 8</xref>). Also there were significant differences between the three groups as regards to PAED score, on arrival to PACU but postoperative, at 10 minutes, 20 min, 30 min, there are significant differences between, Group C with Group K and GROUP D. PAED score was small in Group K and GROUP D than Group C. Also PAED score in Group D smaller than Group K (<xref ref-type="table" rid="table9">Table 9</xref>).</p></sec><sec id="s4"><title>4. Discussion</title><p>Emergence agitation defined as the number of children with disturbance of postoperative behaviour during emergence from sevoflurane anesthesia that measured by agitation scores mentioned in our study. Predisposing factors for emergence agitation include rapid emergence, pre-operative pain and anxiety, an intrinsic characteristic of the anaesthetic, preschool children, baseline mood of the child, and the type of surgery. Emergence agitation is the most common irritant complication during the time of extubation and in early recovery period [<xref ref-type="bibr" rid="scirp.100528-ref14">14</xref>].</p><p>Our study demonstrates that Ketamine and dexmedetomidine reduced the incidence and severity of emergence delirium effectively when compared to normal saline, (as placebo) and the effects of dexmedetomidine being much superior to Ketamine.</p><p>Patel et al. compared the effect of dexmedetomidine infusion versus IV fentanyl. This study concluded that infusion of dexmedetomidine leading to significantly reduced for requirements of the postoperative opioid and also decrease of incidence of emergence agitation in children undergoing tonsillectomies and adenoidectomies [<xref ref-type="bibr" rid="scirp.100528-ref15">15</xref>].</p><p>Also in the study of Jain et al. have shown that dexmedetomidine reduced the rate of emergence agitation ranging between 4.8% and 17% with no hemodynamic effects after IV administration in doses between 0.3 and 1 ug/kg after induction of anesthesia [<xref ref-type="bibr" rid="scirp.100528-ref16">16</xref>]. It proved that α2 agonists decrease emergence agitation by their analgesic effect as well as by reducing the anaesthetic requirements [<xref ref-type="bibr" rid="scirp.100528-ref17">17</xref>].</p><p>In another study conducted by Tawfik M, et al., showed that double-blind, randomized study on 90 children between 4 and 8 years of age and of American Society of Anesthesiologists I undergoing adenotonsillectomy under sevoflurane-based anaesthesia enrolled in the study. Children randomly allocated to one of the two equal groups: group (N) received nalbuphine 0.1 mg/kg, and group (M) received midazolam 0.03 mg/kg. The study drugs were administered 5 min before the end of surgery. In the postanesthesia care unit, the incidence of EA assessed with Aonos four-point scale. The severity of EA was assessed with the pediatric anaesthesia emergence delirium scale upon admission (T0), after 5 min (T5), 10 min (T10), 15 min (T15), and 30 min (T30. The incidence and severity of EA were lower in the group (N) as compared with a group (M) at T0, T5, and T10 16 [<xref ref-type="bibr" rid="scirp.100528-ref18">18</xref>].</p><p>And also study done by. Nan Zhao et al. showed that the incidence of EA in PACU (Aono’s scale ≥ 3: 21.43% vs 57.14%; Pediatric Anesthesia Emergence Delirium [PAED] scale ≥ 10: 21.43% vs 54.76%; both P &lt; 0.01), the percentage of patients with severe EA (PAED score ≥ 15; 7.69 % vs 40.48%; P &lt; 0.01), and peak pain score (2.60 &#177; 2.07 vs 4.10 &#177; 2.49; P = 0.004) were significantly lower in the Group N compared to the Group S. Emergence time was significantly longer in the Group N, but there was no difference in time to discharge from the PACU [<xref ref-type="bibr" rid="scirp.100528-ref19">19</xref>].</p><p>Another study had reported to decrease the rate of emergence agitation and decrease the frequency of postoperative analgesic requirement which is done by Prasad; et al. also found that Dexmedetomidine (0.3 ugs/kg) and ketofol (0.25 mg/kg and 1 mg/kg) caused a significant reduction in the incidence and severity of emergence agitation when compared to control group. Ketofol was as effective as dexmedetomidine in the prevention of emergence agitation when administered before the end of the surgery. Still, children delivered dexmedetomidine was calm and satisfied discharge criteria earlier than ketofol group [<xref ref-type="bibr" rid="scirp.100528-ref20">20</xref>].</p><p>Another study was done by Abd El-Hamid, et al. This study showed that a dose of 1 ug/kg intranasal dexmedetomidine that given after the induction of anaesthesia leading to decrease of post-sevoflurane incidence and severity of emergence agitation in children undergone tonsillectomy and adenoidectomy with no adverse effects and smooth postoperative course [<xref ref-type="bibr" rid="scirp.100528-ref21">21</xref>].</p></sec><sec id="s5"><title>5. Conclusion</title><p>Ketamine and dexmedetomidine reduced the incidence and severity of emergence delirium effectively when compared to normal saline, and the effects of dexmedetomidine being much superior to Ketamine.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Abdelzaam, E.M. and Mahdy, E.W. (2020) Dexmedetomidine versus Ketamine for the Prevention of Emergence Agitation in Pediatric: A Prospective, Randomized, and Controlled Clinical Trial. Open Journal of Anesthesiology, 10, 203-212. https://doi.org/10.4236/ojanes.2020.105018</p></sec></body><back><ref-list><title>References</title><ref id="scirp.100528-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Malarbi, S., Stargatt, R., Howard, K. and Davidson, A. (2011) Characterizing the Behaviour of Children Emerging with Delirium from General Anaesthesia. Pediatric Anesthesia, 21, 942-950. https://doi.org/10.1111/j.1460-9592.2011.03646.x</mixed-citation></ref><ref id="scirp.100528-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Bajwa, S.A., Costi, D. and Cyna, A.M. (2010) A Comparison of Emergence Delirium Scales Following General Anaesthesia in Children. Pediatric Anesthesia, 20, 704-711. https://doi.org/10.1111/j.1460-9592.2010.03328.x</mixed-citation></ref><ref id="scirp.100528-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Chao, Z., Gui, J.H. and Cong, Y. (2017) The Effect of General Anaesthesia for Ambulatory Dental Treatment on Children in Chongqing, Southwest China. Pediatric Anesthesia, 27, 98-105. https://doi.org/10.1111/pan.12983</mixed-citation></ref><ref id="scirp.100528-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Dahmani, S., Mantz, J. and Veyckemans, F. (2012) Case Scenario: Severe Emergence Agitation after Myringotomy in a 3-Year-Old Child. Anesthesiology, 117, 399-406. https://doi.org/10.1097/ALN.0b013e31825fb069</mixed-citation></ref><ref id="scirp.100528-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Somaini, M., Sahilliog lu, E., Marzorati, C., et al. (2015) Emergence Delirium, Pain or Both? A Challenge for Clinicians. Pediatric Anesthesia, 25, 524-529. https://doi.org/10.1111/pan.12580</mixed-citation></ref><ref id="scirp.100528-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Lepousé, C., Lautner, C.A., Liu, L., Gomis, P. and Leon, A. (2006) Emergence Delirium in Adults in the Post-Anaesthesia Care Unit. British Journal of Anaesthesia, 96, 747-753. https://doi.org/10.1093/bja/ael094</mixed-citation></ref><ref id="scirp.100528-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Mohkamkar, M., Farhoudi, F., Alam-Sahebpour, A., et al. (2014) Postanesthetic Emergence Agitation in Pediatric Patients under General Anesthesia. Iranian Journal of Pediatrics, 24, 184-190.</mixed-citation></ref><ref id="scirp.100528-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Shah, A., Mosdossy, G., McLeod, S., Lehnhardt, K., Peddle, M. and Rieder, M. (2011) A Blinded, Randomized Controlled Trial to Evaluate Ketamine/Propofol versus Ketamine Alone for Procedural Sedation in Children. Annals of Emergency Medicine, 57, 425-433. https://doi.org/10.1016/j.annemergmed.2010.08.032</mixed-citation></ref><ref id="scirp.100528-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Andolfatto, G. and Willman, E. (2010) A Prospective Case Series of Pediatric Procedural Sedation and Analgesia in the Emergency Department Using Single-Syringe Ketamine-Propofol Combination (Ketofol). Academic Emergency Medicine, 17, 194-201. https://doi.org/10.1111/j.1553-2712.2009.00646.x</mixed-citation></ref><ref id="scirp.100528-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">David, H. and Shipp, J. (2011) Randomized Controlled Trial of Ketamine/Propofol versus Propofol Alone for Emergency Department Procedural Sedation. Annals of Emergency Medicine, 57, 435. https://doi.org/10.1016/j.annemergmed.2010.11.025</mixed-citation></ref><ref id="scirp.100528-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Almenrader, N., Galante, D. and Engelhardt, T. (2014) Emergence Agitation: Is There a European Consensus? British Journal of Anaesthesia, 113, 515-516. https://doi.org/10.1093/bja/aeu281</mixed-citation></ref><ref id="scirp.100528-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Somaini, M., Engelhardt, T., Fumagalli, R. and Ingelmo, P.M. (2016) Emergence Delirium or Pain after Anaesthesia: How to Distinguish between the Two in Young Children: A Retrospective Analysis of Observational Studies. British Journal of Anaesthesia, 116, 377. https://doi.org/10.1093/bja/aev552</mixed-citation></ref><ref id="scirp.100528-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Locatelli, B.G., Ingelmo, P.M., Emre, S., Meroni, V., Minardi, C., Frawley, G., et al. (2013) Emergence Delirium in Children: A Comparison of Sevoflurane and Desflurane Anesthesia Using the Paediatric Anesthesia Emergence Delirium Scale. Pediatric Anesthesia, 23, 301-308.</mixed-citation></ref><ref id="scirp.100528-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Abdelhalim, A.A. (2013) The Effect of Ketamine versus Fentanyl on the Incidence of Emergence Agitation after Sevoflurane Anaesthesia in Pediatric Patients Undergoing Tonsillectomy with or without Adenoidectomy. Saudi Journal of Anaesthesia, 7, 392-398. https://doi.org/10.4103/1658-354X.121047</mixed-citation></ref><ref id="scirp.100528-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Patel, A., Davidson, M., Tran, M.C., Quraishi, H., Schoenberg, C., Sant, M., et al. (2010) Dexmedetomidine Infusion for Analgesia and Prevention of Emergence Agitation in Children with Obstructive Sleep Apnea Syndrome Undergoing Tonsillectomy and Adenoidectomy. Anesthesia &amp; Analgesia, 111, 1004-1010. https://doi.org/10.1213/ANE.0b013e3181ee82fa</mixed-citation></ref><ref id="scirp.100528-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Jain, S., Sethi, S., Ghai, B. and Ram, J. (2018) Effect of Dexmedetomidine on Emergence Agitation Using Desflurane in Pediatric Cataract Surgery. Saudi Journal of Anaesthesia, 12, 28-34. https://doi.org/10.4103/sja.SJA_235_17</mixed-citation></ref><ref id="scirp.100528-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Ali, W.A., Mohammed, A.K. and Elshorbagy, H.M. (2016) Dexmedetomidine versus Ketofol Effect on the Incidence of Emergence Agitation Associated with Sevoflurane-Based Anaesthesia in Children Undergoing Orthopaedic Surgery. Egyptian Journal of Anaesthesia, 32, 277-284. https://doi.org/10.1016/j.egja.2016.01.004</mixed-citation></ref><ref id="scirp.100528-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">EL-Din, T.M.N., Sharaf, M.S., Alkumity, A.A., Elgammal, M.E. and Salem, E.A. (2018) Midazolam versus Nalbuphine on Prevention of Emergence Agitation in Pediatric Patients on Sevoflurane Anesthesia. Al-Azhar Medical Journal, 4, 573-585.</mixed-citation></ref><ref id="scirp.100528-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Zhao, N., Wu, Y.J. and Yu, C. (2018) Effect of Intravenous Nalbuphine on Emergence Agitation in Children Undergoing Dental Surgery under Sevoflurane Anaesthesia. International Journal of Clinical and Experimental Medicine, 11, 10215-10222.</mixed-citation></ref><ref id="scirp.100528-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Prasad, K., Sophia, P. and Lakshmi, B.S. (2017) Bolus Doses of Ketofol versus Dexmedetomidine for the Prevention of Emergence Agitation in Children: A Prospective Randomized Controlled Clinical Trial. International Journal of Scientific Study, 5, 171-176.</mixed-citation></ref><ref id="scirp.100528-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">El-Hamid, A.M. and Yassin, H.M. (2017) Effect of Intranasal Dexmedetomidine on Emergence Agitation after Sevoflurane Anaesthesia in Children Undergoing Tonsillectomy and/or Adenoidectomy. Saudi Journal of Anaesthesia, 11, 137-143. https://doi.org/10.4103/1658-354X.203020</mixed-citation></ref></ref-list></back></article>